6-Chloro-3-[(3,4-dichlorophenyl)methyl]-2H,3H,4H-[1,3]oxazino[5,6-h]quinoline

Catalog No. :
ACNTAJ070
CAS No. :
338400-83-2
Molecular Formula :
C18H13Cl3N2O
Molecular Weight :
379.67

IUPAC Name:6-chloro-3-(3,4-dichlorobenzyl)-3,4-dihydro-2H-[1,3]oxazino[5,6-h]quinoline

6-Chloro-3-[(3,4-dichlorophenyl)methyl]-2H,3H,4H-[1,3]oxazino[5,6-h]quinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-3-[(3,4-dichlorophenyl)methyl]-2H,3H,4H-[1,3]oxazino[5,6-h]quinoline
IUPAC Name6-chloro-3-(3,4-dichlorobenzyl)-3,4-dihydro-2H-[1,3]oxazino[5,6-h]quinoline
MDL No.MFCD01568323
Molecular FormulaC18H13Cl3N2O
Molecular Weight379.67
SMILESClC1=CC=C(CN2COC3=C4N=CC=CC4=C(Cl)C=C3C2)C=C1Cl
InChI KeyMPOHDHGEKVUNOI-UHFFFAOYSA-N
Synonym6-chloro-3-[(3,4-dichlorophenyl)methyl]-2H,3H,4H-[1,3]oxazino[5,6-h]quinoline;6-CHLORO-3-(3,4-DICHLOROBENZYL)-3,4-DIHYDRO-2H-[1,3]OXAZINO[5,6-H]QUINOLINE;2H-Pyrido[3,2-h]-1,3-benzoxazine, 6-chloro-3-[(3,4-dichlorophenyl)methyl]-3,4-dihydro-
CAS No.338400-83-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNTAJ070 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNTAJ070 route product structure diagram
    ACNTAJ070338400-83-2
Inquiry

2. ACNTAJ070 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNTAJ070 route product structure diagram
    ACNTAJ070338400-83-2
Inquiry

Comments (0)